Neurocrine biosciences to participate at the william blair biotech focus conference

San diego, july 8, 2021 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced that kyle gano, chief business development and strategy officer, will participate in a neuropsychology-focused panel discussion at the william blair biotech focus conference at 12:00 p.m. eastern time on thursday july 15, 2021.
NBIX Ratings Summary
NBIX Quant Ranking